Short-term effect of the combination of hyaluronic acid, chondroitin sulfate, and keratin matrix on early symptomatic knee osteoarthritis
Authors:
Open Access
- 3 September 2019
- journal article
- Published by AVES YAYINCILIK A.Ş. in European Journal of Rheumatology
- Vol. 2 (3) , 106-108
Abstract
Objective: In the last years, symptomatic slow-acting drugs for osteoarthritis (SYSADOA) have been vastly studied and have generated considerable interest among clinicians. SYSADOA are generally used as a ground therapy with the main rationale to reduce the consumption of nonsteroidal anti-inflammatory drugs (NSAIDs) and thus limit the related adverse events. Material and Methods: In this study, we evaluated the short-term effect of an oral combination of hyaluronic acid, chondroitin sulfate, and keratin matrix on early symptomatic knee osteoarthritis. Forty patients were treated for 1 month and were allowed to assume analgesics or NSAIDs if necessary. Results: At 2 months, the mean reduction of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score was 36% (p<0.001), and the mean reduction of the WOMAC pains score was 40% (p<0.001). Only two patients reported a sporadic need to assume analgesics; no patient reported any side effect during the study period. Conclusion: This data demonstrates that the oral combination of hyaluronic acid, chondroitin sulfate, and keratin matrix is safe, well tolerated, and shows a rapid action reducing pain and improving joint function and stiffness in early symptomatic knee osteoarthritis.Keywords
This publication has 20 references indexed in Scilit:
- Emerging regulators of the inflammatory process in osteoarthritisNature Reviews Rheumatology, 2014
- Absorption, distribution and mechanism of action of SYSADOASPharmacology & Therapeutics, 2014
- OARSI guidelines for the non-surgical management of knee osteoarthritisOsteoarthritis and Cartilage, 2014
- Osteoarthritis: A disease of the joint as an organArthritis & Rheumatism, 2012
- The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic reviewOsteoarthritis and Cartilage, 2011
- Oral Administration of High Molecular Weight Hyaluronan (900 kDa) Controls Immune System via Toll-like Receptor 4 in the Intestinal EpitheliumJournal of Biological Chemistry, 2010
- OARSI recommendations for the management of hip and knee osteoarthritisOsteoarthritis and Cartilage, 2010
- Effect of chondroitin sulfate and hyaluronic acid on gene expression in a three-dimensional culture of chondrocytesJournal of Bioscience and Bioengineering, 2005
- EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)Annals of the Rheumatic Diseases, 2003
- Reliability and validity of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index in Italian patients with osteoarthritis of the kneeOsteoarthritis and Cartilage, 2003